Toward a Theranostic Role for Trop2 Immuno-PET
Journal of Nuclear Medicine · 29.10.2026 · jnumed.126.273479
DOI: 10.2967/jnumed.126.273479 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 29.10.2026. Verfasst von Romain-David Seban und 3 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
TO THE EDITOR: We read with great interest the recent article evaluating the novel trophoblast cell-surface antigen 2 (Trop2)–targeted tracer [18F]AlF-RESCA-RT4 for immuno-PET/CT imaging in breast cancer ([1][1]). One hour after tracer injection, uptake of the radiolabeled single-domain antibody
Zitieren
APA
Seban, R. D., Buvat, I., Fouque, J., & Bidard, F. C. (2026). Toward a Theranostic Role for Trop2 Immuno-PET. Journal of Nuclear Medicine, jnumed.126.273479. https://doi.org/10.2967/jnumed.126.273479
Vancouver
Seban RD, Buvat I, Fouque J, Bidard FC. Toward a Theranostic Role for Trop2 Immuno-PET. Journal of Nuclear Medicine. 2026:jnumed.126.273479. doi:10.2967/jnumed.126.273479
BibTeX
@article{Seban2026,
author = {Seban, Romain-David and Buvat, Irene and Fouque, Julien and Bidard, Francois-Clement},
title = {Toward a Theranostic Role for Trop2 Immuno-PET},
journal = {Journal of Nuclear Medicine},
year = {2026},
pages = {jnumed.126.273479},
doi = {10.2967/jnumed.126.273479}
}
EUVIMED